IL6 and thrombocytosis disease: IL-6 is likely to be the main driver, acting synergistically with other interleukins to increase thrombopoietin, of which visceral adipose tissue itself may be an additional source of thrombopoietin, which in turn stimulates megakaryocyte production, leading to thrombocytosis.